Literature DB >> 29302818

Dissemination of Minimally Invasive Liver Resection for Primary Malignancy: Reevaluating Effectiveness.

Patrick R Varley1, Samer T Tohme1, Alexis P Chidi1, Julie Goswami1, Dirk van der Windt1, David A Geller1, Allan Tsung2,3.   

Abstract

BACKGROUND: Experiences at specialized hepatobiliary centers have demonstrated efficacy of minimally invasive liver resection, but concerns exist regarding whether these procedures would remain effective once disseminated to a broad range of clinical practices. We sought to present the first comparison of MILR and open liver resection (OLR) for primary liver malignancy from a nationally representative cancer registry.
METHODS: Cases of liver and intrahepatic bile duct cancer were identified from the National Cancer Data Base Participant Use File. Mixed effects logistic regression and stratified Cox proportional hazards regression were used for analysis. A propensity score matched cohort was used as an alternative form of analysis to evaluate the robustness of results.
RESULTS: A total of 3236 cases were analyzed from 2010 to 2011 with 2581 OLR (80%) and 655 MILR (20%). Of the variation in patient selection for MILR 28.5% was related to treatment at a specific treatment center; however, the proportion of MILR was similar among low-, medium-, and high-volume centers. Overall 90-day mortality was lower at high-volume centers (odds ratio [OR] 0.58; 95% confidence interval [CI] 0.40-0.85) compared with low-volume centers. MILR was similar to OLR in both 90-day mortality and overall survival (OR 0.9; 95% CI 0.62-1.10) and hazard ratio [HR] 0.88 (95% CI 0.72-1.07), regardless of treatment center volume.
CONCLUSIONS: MILR for primary liver malignancy is used across a variety of practice settings, with similar outcomes to OLR. While volume is associated with short-term outcomes of liver resection as a whole, this relationship is not explained by adoption of MILR at low-volume centers.

Entities:  

Mesh:

Year:  2018        PMID: 29302818     DOI: 10.1245/s10434-017-6308-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  4 in total

1.  Critical appraisal of predictive tools to assess the difficulty of laparoscopic liver resection: a systematic review.

Authors:  Julie Hallet; Patrick Pessaux; Kaitlyn A Beyfuss; Shiva Jayaraman; Pablo E Serrano; Guillaume Martel; Natalie G Coburn; Tullio Piardi; Alyson L Mahar
Journal:  Surg Endosc       Date:  2018-10-22       Impact factor: 4.584

2.  Preoperative Prognosticators of Safe Laparoscopic Hepatocellular Carcinoma Resection in Advanced Cirrhosis: a Propensity Score Matching Population-Based Analysis of 1799 Western Patients.

Authors:  Eduardo A Vega; Onur C Kutlu; Katharina Joechle; Nestor De La Cruz; Dicken Ko; Claudius Conrad
Journal:  J Gastrointest Surg       Date:  2019-02-28       Impact factor: 3.452

3.  Minimally Invasive Liver Resection for Early-Stage Hepatocellular Carcinoma: Inconsistent Outcomes from Matched or Weighted Cohorts.

Authors:  Lu Wu; Diamantis I Tsilimigras; Katiuscha Merath; J Madison Hyer; Anghela Z Paredes; Rittal Mehta; Kota Sahara; Fabio Bagante; Eliza W Beal; Feng Shen; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2019-04-22       Impact factor: 3.452

4.  ASO Author Reflections: Evaluating the Impact of Wider Adoption of Minimally Invasive Liver Resection.

Authors:  Patrick R Varley; Allan Tsung
Journal:  Ann Surg Oncol       Date:  2018-11-01       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.